Business Information
The group’s principal activities include developing, manufacturing and marketing implantable and disposable medical devices. The group’s product is microcoil. The group products sold under the trade names HeliPaq(R), HeliPaq SR(R), InterPaq(R), Cerecyte(R), Pharos(TM), MicruSphere(R) and Presidio(TM). The group operates from the United States, Europe, Asia Pacific and other. Of the total revenue in the year 2006, the United States accounted for $16,541, Europe $12,537, Asia Pacific $2,868 and other $835 (thousands).
|
|
Name |
Title
|
Email
|
| John Kilcoyne | Chmn., CEO | N/A | | Robert Stern | COO, Pres. | N/A | | David Watson | VP - Research, Development | N/A | | Edward Ruppel | VP - Technical Operations | N/A | | Jim Robbins | VP - Finance | N/A |
|
|
Year |
Sales |
Net Income |
| 2007 | 58,795 | (5,483) | | 2006 | 32,781 | (8,261) | | 2005 | 24,012 | (6,704)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
